AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2020
Nov 12, 2020
32566_dirs_2020-11-12_aba54401-b7fa-4527-829d-b0dda5086788.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2020-11-11
Reporting Person: Phanstiel S. Louise (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-11 | Common Stock | P | 15000 | $16.6224 | Acquired | 66790 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5000 | Indirect |
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2